Proton Pump Inhibitors and CKD: The Evidence Builds
J Am Soc Nephrol
.
2024 Jul 1;35(7):833-834.
doi: 10.1681/ASN.0000000000000398.
Epub 2024 May 28.
Authors
Morgan E Grams
1
2
3
,
F Perry Wilson
4
5
Affiliations
1
Division of Precision Medicine, Department of Medicine, New York University Grossman School of Medicine, New York, New York.
2
Department of Population Health, New York University Grossman School of Medicine, New York, New York.
3
Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland.
4
Clinical and Translational Research Accelerator, Yale University, New Haven, Connecticut.
5
Section of Nephrology, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.
PMID:
38809613
PMCID:
PMC11230710
(available on
2025-07-01
)
DOI:
10.1681/ASN.0000000000000398
No abstract available
Publication types
Editorial
Comment
MeSH terms
Chronic Disease
Humans
Kidney Diseases / chemically induced
Proton Pump Inhibitors* / adverse effects
Proton Pump Inhibitors* / therapeutic use
Renal Insufficiency, Chronic
Substances
Proton Pump Inhibitors